NDC 17088-0282 – Omalizumab
Omalizumab 300 mg/2mL · Injection, Solution
Product NDC17088-0282
Product details
- Brand name
- Omalizumab
- Generic name
- Omalizumab
- Labeler
- Novartis Pharma Stein AG
- Dosage form
- Injection, Solution
- Marketing category
- DRUG FOR FURTHER PROCESSING
- Marketed since
- August 18, 2023
- Listing expires
- December 31, 2026
Active ingredients
- Omalizumab 300 mg/2mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 17088-0282-1 | 2 mL in 1 SYRINGE, GLASS (17088-0282-1) |
Other Omalizumab products
- 17088-0268 Omalizumab 75 mg/.5mL · Injection, Solution · Novartis Pharma Stein AG
- 17088-0275 Omalizumab 150 mg/mL · Injection, Solution · Novartis Pharma Stein AG
- 17088-0386 Omalizumab 150 mg/1.2mL · Injection, Solution · Novartis Pharma Stein AG